Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 5Breast 3Gastrointestinal 2CNS 2Thoracic 1Other neoplasm 1Other hematologic neoplasm 1Other 1NET 1Lymphoid 1Head & Neck 1Gynecologic 1Endocrine 1

Conditions

Overweight 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Metformin 9Liraglutide 3Exercise 3semaglutide 2Tirzepatide 2Nutrition Assessment 2Lidocaine 2Injections 2Docosahexaenoic Acids 2Diet 2sibutramine 1polyethylene glycol 3350 1oxycodone-acetaminophen 1naloxegol 1naldemedine 1methylnaltrexone 1Ursodeoxycholic Acid 1Tramadol 1Topiramate 1Solutions 1Sennosides 1Resistance Training 1Quality of Life 1Propofol 1Progestins 1Polyethylene Glycols 1Phenolphthalein 1Oxycodone 1Orphenadrine 1Oral Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Magnetic Resonance Spectroscopy × Other × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡